SHR/FubRkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
glomerular filtration trait |
not specified |
168 days
| 10 |
0.52 |
ml/min/100g |
0.08 |
0.25 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
65377 |
117 |
ACI.FHH-(D1Rat298-D1Rat90)/Eur |
creatinine clearance to body weight ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.51 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67728 |
62 |
ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
right nephrectomy |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.58 |
ml/min/100g |
0.02 |
0.07 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67739 |
62 |
ACI.FHH-(D1Rat298-D1Rat90)/Eur |
creatinine clearance to body weight ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.4 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67742 |
62 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 14 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
98 days
| 15 |
0.36 |
ml/min/100g |
0.04 |
0.16 |
blood creatinine analysis |
0.0 |
unx |
14 |
days |
|
101254 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 42 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
126 days
| 5 |
0.14 |
ml/min/100g |
0.03 |
0.06 |
blood creatinine analysis |
0.0 |
unx |
42 |
days |
|
101258 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 42 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
126 days
| 8 |
0.33 |
ml/min/100g |
0.05 |
0.15 |
blood creatinine analysis |
0.0 |
unx |
42 |
days |
|
101259 |
2583 |
BN-Chr 13LH/MavRrrc |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
161 days
| 9 |
0.55 |
ml/min/100g |
0.01 |
0.03 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102035 |
2645 |
SS.ZUC-Leprfa+/+/Slc |
creatinine clearance to body weight ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
glomerular filtration trait |
male |
126 days
| 6 |
0.91 |
ml/min/100g |
0.06 |
0.15 |
urine creatinine analysis |
0.0 |
|
0 |
|
|
101939 |
2642 |
WAG/Nov |
creatinine clearance to body weight ratio |
controlled sucrose content drinking water (4 %) (for 2 days) and solid food deprivation (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
glomerular filtration trait |
not specified |
0 days
| 4 |
0.22 |
ml/min/100g |
0.02 |
0.05 |
urine creatinine analysis |
0.0 |
|
0 |
|
|
107193 |
3078 |
ACI/Eur |
creatinine clearance to body weight ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.46 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67726 |
62 |
ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.56 |
ml/min/100g |
0.02 |
0.07 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67729 |
62 |
ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.52 |
ml/min/100g |
0.04 |
0.14 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67734 |
62 |
ACI.FHH-(D3Wox2-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
control condition |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.75 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67727 |
62 |
ACI/Eur |
creatinine clearance to body weight ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.5 |
ml/min/100g |
0.02 |
0.07 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67730 |
62 |
ACI/Eur |
creatinine clearance to body weight ratio |
right nephrectomy |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.41 |
ml/min/100g |
0.01 |
0.03 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67735 |
62 |
LH-Chr 13BN/Mav |
creatinine clearance to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
133 days
| 10 |
0.49 |
ml/min/100g |
0.01 |
0.03 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102030 |
2645 |
WI |
creatinine clearance to body weight ratio |
controlled in utero environment (for 21 days) and standard diet (100 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
glomerular filtration trait |
male |
102 days
| 6 |
0.54 |
ml/min/100g |
0.06 |
0.13 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
101065 |
2563 |
WI |
creatinine clearance to body weight ratio |
controlled in utero environment (for 21 days) and standard diet (50 % of calories) (for 21 days) |
Ceravolo GS, et al., Life Sci. 2007 Jan 30;80(8):782-7. Epub 2006 Nov 10. |
glomerular filtration trait |
male |
102 days
| 6 |
0.48 |
ml/min/100g |
0.08 |
0.18 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
101066 |
2563 |
SS.ZUC-Leprfa-/-/Slc |
creatinine clearance to body weight ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 7 |
0.28 |
ml/min/100g |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
101879 |
2641 |
BRAT-Avpdi/BluHsd |
creatinine clearance to body weight ratio |
sodium chloride solution (1 ml) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
glomerular filtration trait |
not specified |
0 days
| 4 |
0.2 |
ml/min/100g |
0.02 |
0.03 |
urine creatinine analysis |
0.0 |
|
0 |
|
|
107192 |
3078 |
WAG/Nov |
creatinine clearance to body weight ratio |
desmopressin (100 ug/kg) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
glomerular filtration trait |
not specified |
0 days
| 4 |
0.16 |
ml/min/100g |
0.02 |
0.05 |
urine creatinine analysis |
0.0 |
|
0 |
|
|
107194 |
3078 |
ACI.FHH-(D1Rat475-D1Rat90)(D3Rat84-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
5 |
0.31 |
ml/min/100g |
0.06 |
0.13 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67743 |
62 |
SS.ZUC-Leprfa+/+/Slc |
creatinine clearance to body weight ratio |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 10 |
0.39 |
ml/min/100g |
0.04 |
0.13 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
101878 |
2641 |
BN/NHsdMcwi |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
161 days
| 10 |
0.44 |
ml/min/100g |
0.03 |
0.09 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102032 |
2645 |
SHR/FubRkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
glomerular filtration trait |
female |
168 days
| 10 |
0.47 |
ml/min/100g |
0.05 |
0.16 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
68181 |
309 |
MWF/FubRkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
glomerular filtration trait |
female |
168 days
| 18 |
0.38 |
ml/min/100g |
0.02 |
0.08 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
68183 |
309 |
ACI.FHH-(D3Wox2-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.78 |
ml/min/100g |
0.04 |
0.14 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67732 |
62 |
BN-Chr 13LH/MavRrrc |
creatinine clearance to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
133 days
| 9 |
0.49 |
ml/min/100g |
0.02 |
0.06 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102031 |
2645 |
LH/Mav |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
161 days
| 10 |
0.46 |
ml/min/100g |
0.01 |
0.03 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102033 |
2645 |
LH-Chr 13BN/Mav |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
161 days
| 10 |
0.47 |
ml/min/100g |
0.01 |
0.03 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102034 |
2645 |
BN/NHsdMcwi |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
175 days
| 10 |
0.44 |
ml/min/100g |
0.02 |
0.06 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102036 |
2645 |
LH-Chr 13BN/Mav |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
175 days
| 10 |
0.45 |
ml/min/100g |
0.02 |
0.06 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102038 |
2645 |
SS/NEisSlc |
creatinine clearance to body weight ratio |
vehicle control condition (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
glomerular filtration trait |
not specified |
547 days
| 10 |
0.38 |
ml/min/100g |
0.03 |
0.08 |
plasma creatinine analysis |
0.0 |
|
0 |
|
|
107441 |
2339 |
BRAT-Avpdi/BluHsd |
creatinine clearance to body weight ratio |
desmopressin (100 ug/kg) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
glomerular filtration trait |
not specified |
0 days
| 5 |
0.09 |
ml/min/100g |
0.03 |
0.06 |
urine creatinine analysis |
0.0 |
|
0 |
|
|
107195 |
3078 |
SD |
creatinine clearance to body weight ratio |
doxorubicin (5 mg/kg) (between 6 and 7 days) |
Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. |
glomerular filtration trait |
female |
96 days-121 days |
7 |
0.74 |
ml/min/100g |
0.08 |
0.2 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
0.0 |
|
0 |
|
|
110189 |
3166 |
MWF |
creatinine clearance to body weight ratio |
doxorubicin (5 mg/kg) (between 6 and 7 days) |
Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. |
glomerular filtration trait |
female |
96 days-121 days |
11 |
0.62 |
ml/min/100g |
0.06 |
0.21 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
0.0 |
|
0 |
|
|
110191 |
3166 |
ACI/Eur |
creatinine clearance to body weight ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.46 |
ml/min/100g |
0.05 |
0.17 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67740 |
62 |
BN-Chr 13LH/MavRrrc |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
175 days
| 9 |
0.49 |
ml/min/100g |
0.02 |
0.06 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102039 |
2645 |
MWF/FubRkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
glomerular filtration trait |
not specified |
168 days
| 18 |
0.46 |
ml/min/100g |
0.05 |
0.21 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
65379 |
117 |
ACI.FHH-(D1Rat298-D1Rat90)/Eur |
creatinine clearance to body weight ratio |
NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.49 |
ml/min/100g |
0.01 |
0.03 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67733 |
62 |
ACI.FHH-(D1Rat298-D1Rat90)/Eur |
creatinine clearance to body weight ratio |
right nephrectomy |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.46 |
ml/min/100g |
0.02 |
0.07 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67738 |
62 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 14 days) then controlled candesartan content drinking water (1 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
98 days
| 10 |
0.36 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
0.0 |
unx |
14 |
days |
|
101255 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 14 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
98 days
| 9 |
0.34 |
ml/min/100g |
0.03 |
0.08 |
blood creatinine analysis |
0.0 |
unx |
14 |
days |
|
101256 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 42 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
126 days
| 5 |
0.23 |
ml/min/100g |
0.04 |
0.08 |
blood creatinine analysis |
0.0 |
unx |
42 |
days |
|
101261 |
2583 |
BN/NHsdMcwi |
creatinine clearance to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
133 days
| 10 |
0.46 |
ml/min/100g |
0.03 |
0.09 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102028 |
2645 |
SS.ZUC-Leprfa-/-/Slc |
creatinine clearance to body weight ratio |
control condition |
Hattori T, et al., Nutr Diabetes. 2011 Jan 31;1:e1. doi: 10.1038/nutd.2010.1. |
glomerular filtration trait |
male |
126 days
| 7 |
0.18 |
ml/min/100g |
0.02 |
0.05 |
urine creatinine analysis |
0.0 |
|
0 |
|
|
101940 |
2642 |
SS/NEisSlc |
creatinine clearance to body weight ratio |
controlled E4177 content drinking water (1.66 mg/kg/d) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
glomerular filtration trait |
not specified |
547 days
| 10 |
0.44 |
ml/min/100g |
0.02 |
0.07 |
plasma creatinine analysis |
0.0 |
|
0 |
|
|
107444 |
2339 |
MWF |
creatinine clearance to body weight ratio |
control condition |
Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. |
glomerular filtration trait |
female |
96 days-121 days |
10 |
0.88 |
ml/min/100g |
0.08 |
0.25 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
0.0 |
|
0 |
|
|
110190 |
3166 |
WAG/Nov |
creatinine clearance to body weight ratio |
sodium chloride solution (1 ml) (for 2 days) |
Ivanova LN, et al., Exp Physiol. 2013 Nov;98(11):1608-19. doi: 10.1113/expphysiol.2013.073163. Epub 2013 Aug 16. |
glomerular filtration trait |
not specified |
0 days
| 4 |
0.18 |
ml/min/100g |
0.03 |
0.07 |
urine creatinine analysis |
0.0 |
|
0 |
|
|
107191 |
3078 |
ACI.FHH-(D3Wox2-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
right nephrectomy |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
12 |
0.61 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67737 |
62 |
SS.ZUC-Leprfa-/-/Slc |
creatinine clearance to body weight ratio |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 12 |
0.17 |
ml/min/100g |
0.02 |
0.07 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
101880 |
2641 |
SS/NEisSlc |
creatinine clearance to body weight ratio |
controlled cilazapril content drinking water (0.94 mg/kg/d) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
glomerular filtration trait |
not specified |
547 days
| 10 |
0.45 |
ml/min/100g |
0.07 |
0.22 |
plasma creatinine analysis |
0.0 |
|
0 |
|
|
107443 |
2339 |
ACI.FHH-(D3Wox2-D3Rat59)/Eur |
creatinine clearance to body weight ratio |
right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) |
Van Dijk SJ, et al., Kidney Int. 2006 |
glomerular filtration trait |
male |
168 days-175 days |
11 |
0.63 |
ml/min/100g |
0.04 |
0.13 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
67741 |
62 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 14 days) then controlled hydralazine content drinking water (15 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
98 days
| 6 |
0.33 |
ml/min/100g |
0.06 |
0.15 |
blood creatinine analysis |
0.0 |
unx |
14 |
days |
|
101257 |
2583 |
SHR/NCrlCrlj |
creatinine clearance to body weight ratio |
unilateral nephrectomy (for 42 days) then controlled delapril content drinking water (30 mg/kg/d) (for 28 days) |
Kohara K, et al., Hypertension. 1993 Jun;21(6 Pt 2):975-9. |
glomerular filtration trait |
male |
126 days
| 9 |
0.33 |
ml/min/100g |
0.03 |
0.1 |
blood creatinine analysis |
0.0 |
unx |
42 |
days |
|
101260 |
2583 |
LH/Mav |
creatinine clearance to body weight ratio |
control condition |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
133 days
| 10 |
0.45 |
ml/min/100g |
0.01 |
0.03 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102029 |
2645 |
LH/Mav |
creatinine clearance to body weight ratio |
controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 7 days) then water (for 12 days) |
Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93. |
glomerular filtration trait |
male |
175 days
| 10 |
0.46 |
ml/min/100g |
0.01 |
0.03 |
automated blood creatinine analysis |
0.0 |
|
0 |
|
. |
102037 |
2645 |
SS.ZUC-Leprfa+/+/Slc |
creatinine clearance to body weight ratio |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
glomerular filtration trait |
male |
91 days
| 8 |
0.43 |
ml/min/100g |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
0 |
|
|
101877 |
2641 |
SS/NEisSlc |
creatinine clearance to body weight ratio |
controlled cilazapril content drinking water (0.16 mg/kg/d) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
glomerular filtration trait |
not specified |
547 days
| 10 |
0.42 |
ml/min/100g |
0.02 |
0.07 |
plasma creatinine analysis |
0.0 |
|
0 |
|
|
107442 |
2339 |
SD |
creatinine clearance to body weight ratio |
control condition |
Eisenberger U, etal., Ren Physiol Biochem. 1995 Mar-Apr;18(2):89-96. doi: 10.1159/000173904. |
glomerular filtration trait |
female |
96 days-121 days |
7 |
0.84 |
ml/min/100g |
0.05 |
0.13 |
creatinine analysis by Jaffe reaction with spectrophotometric readout |
0.0 |
|
0 |
|
|
110188 |
3166 |
MWF-Chr 6SHR/Rkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
glomerular filtration trait |
not specified |
168 days
| 19 |
0.59 |
ml/min/100g |
0.04 |
0.17 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
65378 |
117 |
MWF-Chr 6SHR/Rkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
glomerular filtration trait |
female |
168 days
| 20 |
0.37 |
ml/min/100g |
0.04 |
0.18 |
blood creatinine analysis |
0.0 |
|
0 |
|
|
68182 |
309 |